secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0000950170-22-021516
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix Q3 adjusted EPS $0.40 misses; FY2022 EBITDA guidance lowered to $240-245M
--------------------------------------------------------------------------------

- Adjusted EPS from continuing operations $0.40 vs $0.46 YoY; GAAP EPS $0.35.
- Net revenue $490M, down slightly from $493M YoY; same-unit revenue declined 3.2%.
- Adjusted EBITDA $58.3M, down from $73.4M YoY; FY2022 guidance $240-245M.
- CEO cites operational challenges in billing/collections and payor mix as headwinds.
- Steps underway with R1 partner to improve revenue cycle; cost cuts starting Q4.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017022021516/0000950170-22-021516-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017022021516/md-20221103.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-021516

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer